SLC5A2 and diabetes mellitus: Large clinical trials examining the efficacy of SGLT2 inhibitors fortreatment of diabetes or cardiovascular defects, concomitantly demonstratedincreased serum Mg2+ levels [84, 85].One case even showed that treatment with SGLT2 inhibitors were more efficient inreplenishing Mg2+ levels compared with oralMg2+ supplementation [86].